These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 10976431)

  • 21. Molecular interactions of vasoactive systems in cardiovascular damage.
    Bader M
    J Cardiovasc Pharmacol; 2001 Nov; 38 Suppl 2():S7-9. PubMed ID: 11811382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The kinin system: suggestions to broaden some prevailing concepts.
    Erdös EG; Deddish PA
    Int Immunopharmacol; 2002 Dec; 2(13-14):1741-6. PubMed ID: 12489787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does insulin release kinins in rats?
    Damas J; Garbacki N; Lefèbvre PJ
    Eur J Pharmacol; 2005 Nov; 525(1-3):154-60. PubMed ID: 16297383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benazepril, an angiotensin-converting enzyme inhibitor, alleviates renal injury in spontaneously hypertensive rats by inhibiting advanced glycation end-product-mediated pathways.
    Liu XP; Pang YJ; Zhu WW; Zhao TT; Zheng M; Wang YB; Sun ZJ; Sun SJ
    Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):287-96. PubMed ID: 19018797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of Angiotensin-(1-7) with kinins in the kidney circulation: Role of B
    Mendes EP; Ianzer D; Peruchetti DB; Santos RAS; Vieira MAR
    Peptides; 2024 Sep; 179():171246. PubMed ID: 38821119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mechanism of action of the angiotensin converting enzyme inhibitors: role of kallikrein kinins and prostaglandins].
    Rosen B; Weiss M; Zimlichman R
    Harefuah; 1992 Mar; 122(5):305-8. PubMed ID: 1572577
    [No Abstract]   [Full Text] [Related]  

  • 27. The kallikrein-kinin system, angiotensin converting enzyme inhibitors and insulin sensitivity.
    Damas J; Garbacki N; Lefèbvre PJ
    Diabetes Metab Res Rev; 2004; 20(4):288-97. PubMed ID: 15250031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The kallikrein-kinin and renin-angiotensin systems in the kidney of an African lungfish, Protopterus annectens.
    Masini MA; Napoli L; Sturla M; Uva B
    Gen Comp Endocrinol; 1996 Jul; 103(1):93-100. PubMed ID: 8812341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isoflavone genistein inhibits the angiotensin-converting enzyme and alters the vascular responses to angiotensin I and bradykinin.
    Montenegro MF; Pessa LR; Tanus-Santos JE
    Eur J Pharmacol; 2009 Apr; 607(1-3):173-7. PubMed ID: 19233159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Towards understanding the kallikrein-kinin system: insights from measurement of kinin peptides.
    Campbell DJ
    Braz J Med Biol Res; 2000 Jun; 33(6):665-77. PubMed ID: 10829095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potent antihypertrophic effect of the bradykinin B2 receptor system on the renal vasculature.
    Tsuchida S; Miyazaki Y; Matsusaka T; Hunley TE; Inagami T; Fogo A; Ichikawa I
    Kidney Int; 1999 Aug; 56(2):509-16. PubMed ID: 10432390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different reactivity to angiotensin II of peripheral and renal arteries in spontaneously hypertensive rats: effect of acute and chronic angiotensin converting enzyme inhibition.
    Guidi E; Hollenberg NK
    J Hypertens Suppl; 1986 Dec; 4(6):S480-2. PubMed ID: 11538668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of bradykinin in the cardiovascular effects of angiotensin-converting enzyme inhibitors].
    Galinier M; Pathak A; Baixas C; Alhabaj S; Fallouh V; Roncali J; Schmutz L; Massabuau P; Fauvel JM; Bounhoure JP
    Arch Mal Coeur Vaiss; 2002 Feb; 95 Spec 4(5 Spec 4):37-40. PubMed ID: 11933554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kidney angiotensin receptors and their role in renal pathophysiology.
    Sandberg K; Ji H
    Semin Nephrol; 2000 Sep; 20(5):402-16. PubMed ID: 11022892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kinins in the cardiovascular system.
    Schölkens BA
    Immunopharmacology; 1996 Jun; 33(1-3):209-16. PubMed ID: 8856152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
    Abassi Z; Armaly Z; Nakhoul F; Hoffman A
    Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do the cardiovascular effects of angiotensin-converting enzyme (ACE) I involve ACE-independent mechanisms? new insights from proline-rich peptides of Bothrops jararaca.
    Ianzer D; Santos RA; Etelvino GM; Xavier CH; de Almeida Santos J; Mendes EP; Machado LT; Prezoto BC; Dive V; de Camargo AC
    J Pharmacol Exp Ther; 2007 Aug; 322(2):795-805. PubMed ID: 17475904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The kininogen gene family in obstructive uropathy.
    El-Dahr SS
    Semin Nephrol; 1998 Nov; 18(6):633-40. PubMed ID: 9819154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bradykinin and inhibition of angiotensin-converting enzyme in hypertension.
    Agarwal R
    N Engl J Med; 1999 Mar; 340(12):967-8; author reply 968-9. PubMed ID: 10094649
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.